Breakthrough clinical trial results for "PatientPartner," a new mobile
game application designed by scientists and researchers at CyberDoctor,
document for the first time the effectiveness of a story-driven game in
changing health behavior and biomarkers. Results of the clinical trial
demonstrating increased adherence among patients with diabetes were
announced at the Health
2.0 Conference, October 2nd, in Santa Clara, CA. The
unique, universal, non-disease specific approach allows PatientPartner
to be effective in improving adherence in all patient populations.
PatientPartner was tested with a population of 100 non-adherent patients
with diabetes at Pinnacle Health Systems located in Hershey, PA.
Diabetic patients were chosen because results could be measured by blood
glucose levels, a reliable biomarker that allowed researchers to obtain
both qualitative and quantitative findings.
Patients with diabetes who used PatientPartner showed significant
improvement in three key areas - medication, diet, and exercise:
Medication adherence increased by 37%, from 58% to 95% - equivalent to
three additional days of medication adherence per week.
Diet adherence increased by 24% - equivalent to two days of additional
adherence a week.
Exercise adherence increased by 14% - equivalent to one additional day
of adherence per week.
HbA1c (a blood sugar measure) decreased from 10.7% to 9.7%.
PatientPartner is a short, fun, narrative game in which patients choose
a character and make decisions as the character, and then as themselves.
PatientPartner analyzes how they make these choices and offers patients
targeted feedback. Patients then can play sophisticated training modules
to learn how to make better choices. The methodology of PatientPartner
is based on validated theories of behavioral change and decision-making
derived from science wide complexity theory applicable to all people and
As an additional reward for playing the game, patients will receive
discounts of up to 45% on their medications and co-pays and can earn
points to redeem for gift cards and other prizes.
The benefits of improving patient adherence are tremendous. In the U.S.
alone, non-adherence leads to 125,000 needless deaths1 and
300 billion wasted dollars2 each year.
"The findings are significant because this is an
independent, IRB-approved clinical trial proving that PatientPartner can
dramatically improve patient health," said Akhila Satish, M.S.,
CyberDoctor founder and CEO. "While there are many health apps available
today, this clinical trial proves that a single 15 minute use of our app
actually impacts patient behavior and biological measures, and at a
consistently higher level than previous adherence interventions."
Mantosh Dewan, M.D., on the board of directors of CyberDoctor,
commented, "As a physician who has seen the terrible effects of
non-adherence on patients in my own practice, I am tremendously
encouraged by the clinical trial results for PatientPartner. Because
PatientPartner is not connected to a doctor or electronic medical
record, this easy-to-use, scalable application can reach more patients
in a fast, inexpensive way and create longer lasting results than most
PatientPartner is available in the iTunes
store and works on the iPhone and iPod Touch. For information on
PatientPartner, visit www.mypatientpartner.com.
Headquartered in Mountain View, CA, CyberDoctor is dedicated to making
healthcare communication more easy, effective and efficient. The company
focuses on quality of care principles to guide patient-physician
interactions in today's new age of technology. The scientists,
researchers and clinicians at CyberDoctor strongly believe that
efficient and effective healthcare interaction tools will make a
tremendous impact on the quality, cost and delivery of care. For more
information visit our website www.mycyberdoctor.com.
CyberDoctor CEO and founder Akhila Satish, M.S., who was named one of the
top five women CEOs to watch at this year's Health 2.0
conference, previously worked in life sciences research at the
University of Michigan and the National Institutes of Health. She holds
a graduate degree in biotechnology from the University of Pennsylvania.
Ms. Satish drives CyberDoctor's academic approach to healthcare
technology and its focus on the final, measurable clinical outcome of
the patient experience.
1Therapeutics and Clinical Risk Management, 2005:
1:189-199, Martin et al, 2.
2New England HealthCare Institute, "Thinking Outside the Pillbox,"
August 12, 2009.